Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Pre-close Trading Statement

3 Apr 2008 07:00

Marston's PLC03 April 2008 3 April 2008 Marston's PLC Pre-Close Trading Statement The Board of Marston's PLC issues the following trading update following the endof the first half of the current financial year on 29 March 2008. Trading In Marston's Inns & Taverns, our managed pub division, like-for-like sales forthe 24 weeks to 15 March 2008* were 0.3% above last year against strongcomparatives, with reported like-for-like sales growth of 7.0% for the sameperiod last year. Food sales have continued to show excellent like-for-likesales growth of 7.8% in the same 24 week period, although higher margin wetsales and machine income were 3.1% and 10.3% below last year respectively. Ournew build programme continues to generate attractive returns with 8 new pubsopened in the first half-year, and we expect to open a further 12 in the secondhalf-year. In Marston's Pub Company, our tenanted and leased pub division, like-for-likeprofit was slightly below last year in the period with growth in rental incomeoffset by volumes and machine income in line with market trends. In Marston's Beer Company, whilst overall volumes remain below last year we haveincreased market share with continued good performance in the premium alesegment. Costs across the Group have been well controlled, notwithstanding inflationarypressures in brewing and food purchasing, but the changes in sales mix describedabove will continue to have an impact on operating margins. In our interim results statement due to be issued on 23 May 2008 we expect toreport Group sales up by around 4% compared to last year for the 26 week period,reflecting the acquisitions of Sovereign Inns, Eldridge Pope and RingwoodBrewery in 2007. Operating profit (before interest and taxation) is expected tobe in line with last year, although profit before taxation will reflect thehigher interest costs associated with the £150 million share buy-back programmein 2007. Earnings per share will also reflect the related reduction of around9.5% in the average number of shares in issue and an expected lower underlyingrate of taxation. Underlying cash generation remains strong with net debtestimated to be approximately £1.27 billion at the half year-end. Outlook We remain cautious about the outlook for 2008, and the recent increase in beerduty adds to the pressures on tenants and free trade operators in an alreadychallenging trading environment. However with our high quality pub estate and our continuing investment innew-build pubs, we are well positioned to exploit favourable trends includingmarket growth in casual dining, and our value for money offers and mid-marketposition are well suited to the current economic climate. Notwithstanding thecurrent testing market conditions our expectations for the financial year as awhole remain unchanged. * In 2007 Easter fell in the second half-year. Like-for-like sales are reportedfor the 24 week period in order to be on a comparable basis to last year. ENQUIRIES:Marston's, PLC Hudson SandlerRalph Findlay, Chief Executive Andrew HayesPaul Inglett, Finance Director Nick LyonTel: 01902 329516 James White Tel: 020 7796 4133 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.